Interaction of baroreceptor and chemoreceptor
reflex control of sympathetic nerve activity in
normal humans.
V K Somers, … , A L Mark, F M Abboud
J Clin Invest.
1991;
87(6)
:1953-1957.
https://doi.org/10.1172/JCI115221
.
Animal studies have demonstrated that activation of the baroreflex by increases in arterial
pressure inhibits cardiovascular and ventilatory responses to activation of peripheral
chemoreceptors (PC) with hypoxia. In this study, we examined the influences of baroreflex
activation on the sympathetic response to stimulation of PC and central chemoreceptors in
humans. PC were stimulated by hypoxia (10% O2/90% N2) (n = 6) and central
chemoreceptors by hypercapnia (7% CO2/93% O2) (n = 6). Responses to a cold pressor
stimulus were also obtained as an internal reflex control to determine the selectivity of the
interactive influence of baroreflex activation. Baroreflex activation was achieved by raising
mean blood pressure by greater than 10 mmHg with intravenous infusion of phenylephrine
(PE). Sympathetic nerve activity (SNA) to muscle was recorded from a peroneal nerve
(microneurography). During hypoxia alone, SNA increased from 255 +/- 92 to 354 +/- 107
U/min (P less than 0.05). During PE alone, mean blood pressure increased and SNA
decreased to 87 +/- 45 U/min (P less than 0.05). With hypoxia during baroreflex activation
with PE, SNA did not increase (50 +/- 23 U/min). During hypercapnia alone, SNA increased
from 116 +/- 39 to 234 +/- 72 U/min (P less than 0.01). Hypercapnia during baroreflex
activation with PE increased SNA from 32 +/- 25 U/min during PE alone to 61 +/- 26 […]
Research ArticleFind the latest version:
Interaction
of
Baroreceptor
and
Chemoreceptor
Reflex Control
of
Sympathetic
Nerve
Activity in
Normal Humans
VirendK.Somers, AllynL. Mark, andFrancoisM.Abboud
DepartmentsofInternalMedicineandPhysiologyandBiophysics, Cardiovascular Center, UniversityofIowa, andthe Veterans Administration MedicalCenter,IowaCity,Iowa55242
Abstract
Animal studies havedemonstratedthat activation of the barore-flex by increases in arterial pressure inhibits cardiovascular andventilatoryresponses toactivation ofperipheral chemore-ceptors(PC)withhypoxia.Inthis study, weexaminedthe influ-encesof baroreflex activationon thesympatheticresponse to
stimulationofPCand centralchemoreceptors in humans. PC
werestimulatedbyhypoxia (10%
02/90%
N2) (n=6)
and cen-tralchemoreceptorsbyhypercapnia(7%C02/93% 02) (n=6).Responsesto a cold pressor stimulus were also obtained as an internalreflexcontrol todeterminetheselectivity ofthe inter-active influence of baroreflexactivation. Baroreflex activation was achieved byraisingmean blood pressureby>10 mmHg
withintravenousinfusion of phenylephrine (PE). Sympathetic
nerveactivity (SNA)to muscle was recordedfromaperoneal
nerve (microneurography). During hypoxia alone, SNA in-creased from255±92 to354±107U/min (P<0.05). During
PE alone, mean blood pressureincreasedandSNAdecreased to87±45 U/min (P<0.05). With hypoxia during baroreflex activationwithPE,SNAdid notincrease(50±23
U/min).
Dur-ing hypercapniaalone,SNA increased from 116±39to234±72 U/min (P<0.01). Hypercapnia during baroreflex activation
with PEincreasedSNA from32±25U/minduring PE alone to 61±26 U/min during hypercapnia and PE (P < 0.05). Like hypercapnia (but unlike hypoxia) thecold pressor test also in-creasedSNAduringPE.We conclude thatbaroreflex activa-tionselectively abolishestheSNAresponse tohypoxiabut not tohypercapniaorthe cold pressor test. Theinhibitory interac-tionof thebaroreflexand theperipheral chemoreflexmay be
explained byconvergence ofbaroreceptorandperipheral che-moreceptorafferentson neurons in the medulla.(J. Clin. In-vest. 1991.87:1953-1957.)Key words: hypoxia-
hypercapnia.
baroreflex*chemoreflex
Introduction
Baroreceptorandchemoreceptor reflexesexertconsiderable
in-fluenceonautonomiccontrol of the circulation, especially in situations
involving
stressors such asmarked changesinbloodpressure andinblood levelsofoxygen and carbondioxide.The
individual contributions of baroreflexesand theirresponsesto blood pressurealterationsandof chemoreflexesand their re-sponses tohypoxiaandhypercapniahave beenextensively
stud-iedin bothanimals(1,2)andhumans(3, 4).Thus far, however,
Addressreprintrequests to Dr.FrancoisM.Abboud, Departmentof InternalMedicine, University of Iowa College of Medicine, Iowa City, IA 52242.
Receivedfor publication 9July1990 and in revisedform 14 De-cember 1990.
The Journalof ClinicalInvestigation, Inc.
Volume87,June 1991, 1953-1957
interactionsofthese reflexes haveonlybeen studied in animals. Heistad et al. have shown in dogsthat baroreflex activation inhibits anddeactivationaugments theventilatoryresponseto
stimulation of theperipheral chemoreceptors
(5).
Inaddition,
Mancia et al. have demonstrated that vasoconstrictor re-sponses toperipheral chemoreceptor stimulationareinhibited byelevation of bloodpressureand activation ofbaroreceptor
reflexes
(6).
Ithasbeen difficult to study the interaction ofbaroreceptor
andchemoreceptorreflexesin humansusingmeasurementsof vascularresistance and arterial pressure because the stimulito
these reflexes (vasoactive drugs andhypoxia) produce direct andconfoundingeffectsonthecirculation. However,withthe
useofmicroneurographic recordingsofsympatheticnerve
ac-tivity (SNA),' it is feasible to study the interaction of these reflexes in normal humans. We have shown that bothhypoxia
(peripheralchemoreceptorstimulation [7, 8]) and hypercapnia
(primarily central chemoreceptor stimulation [9, 10]) trigger
increasesinSNA in humans(4). Furthermore,baroreflex acti-vationinhibits SNA. We, therefore, examined the effect ofbaro-reflex activation(elevationof systemicpressureusing
intrave-nousphenylephrine infusions)onsympatheticnerve responses tostimulation ofperipheralchemoreceptors (by hypoxia), to
stimulationofcentral chemoreceptors (byhypercapnia),andto acoldpressorstimulus(usedas aninternal reflexcontrol).
Methods
10 normal human volunteers (7 male, 3 female) aged 24±3 yr were studied. All were nonsmokers and receiving no medication. Measure-ments were takenof heart rate (EKG), breathing patterns (pneumo-tach), blood pressure (Physio-Control Lifestat 200 semiautomated sphygmomanometer; Redmond, WA), 02 saturation (Nellcor N-l 100 Cpulseoximeter, Hayward, CA), end tidal CO2 (472 1OA capnometer; Hewlett-Packard Co., Andover, MA), central venous pressure, and sympathetic nerveactivity to muscleusing microneurography (11). SNAwasmeasureddirectlybyinsertingatungstenmicroelectrode into a nervefascicle tomuscle in the peroneal nerve. Sympathetic bursts wereidentified by inspection of the mean voltage neurogram and sym-patheticactivity was calculated as bursts/minXmeanburst amplitude andexpressed inarbitrary units (12). We also measured minute venti-lation usingaventilation monitor (LS-75; Bourns, Riverside, CA).
Subjectswereexposedtogasmixtures intendedtoinduce either hypoxia (10% 02, 90% N2) or hypercapnia (7%CO2,93%02)- Subjects underwent measurement of baseline variables for 3 min while breath-ingroomair. Then using a three-way valve, the subjects were exposed toeither the hypoxic (six subjects)orhypercapnic(sixsubjects) stress-orsfor 5 min. Average values forthe5-minperiod ofgas exposurewere usedin the comparisons.Inonesubject, responses to hypercapnia with andwithout phenylephrine (PE) were obtained over 3 min because of
1.Abbreviations usedinthispaper:CPT, cold pressortest;CVP, central
venous pressure; MBP, mean blood pressure; SNA, sympathetic nerve
activity; VE,minute ventilation.
inability to comfortably tolerate the stress for a longer period. Note that responses tohypoxiawith and without PE were obtained in six subjects and tohypercapniawith andwithoutPEinsixsubjects.Twosubjects underwentboth protocols (on separate days) and provided data for both thehypoxic as well as the hypercapnic stimuli. Exposuretoeach of the gasmixtureswas performedin the baselinestateand during
elevation of systemic pressure usingan intravenousinfusion of PE.
InfusionofPEwastitratedtomaintainmeanblood pressure (MBP) at 210 mmHg above baseline (thereby activating thebaroreflexes).The
interventionsincluded: (a) hypoxia or hypercapnia alone;(b)PEalone; (c)hypoxia orhypercapnia duringphenylephrineinfusion.Theorder of the interventionswasrandomly allocated. At least 30 min separated the endofoneintervention from thebeginningofthe next. Exposure to gas mixturesduringthePEinfusionswasperformed only aftera con-stantinfusionof PE for at least 10 mintoensureasteadystate.
Duringhypoxia, hypocapniasecondary to thehyperventilationwas avoided bytitrating CO2tomaintainisocapnia.
Weexamined the effects of hypoxia and hypercapniaonSNA and compared theseeffectstothose recorded when thebaroreflexeswere
activated duringthe PEinfusion.Infour subjects,wefurtherexamined theeffects of the cold pressortest(CPT)onSNA both in the baseline state aswellasduringthe PEinfusion. The CPTwasperformed by
havingsubjects insert their hands to a predetermined depth into a
con-tainerof ice for 2 min.
Theeffectsof hypoxia,hypercapnia,andthe CPT during the base-line state were compared with their effects during baroreflex activation
(bythe PEinfusion) usingtheWilcoxon'ssignedrank test. To assess minute by minute changes in the measuredvariables,the data were
furtheranalyzedusingarepeated measures one-way analysisof vari-ance(TableIII). Significancewasassumedatthe 5% level. Valuesare expressedasmean±standarderror.
Thestudywasapprovedby theUniversityofIowa HumanSubjects
ReviewCommittee,and eachsubjectgaveinformedwrittenconsent.
Results
(I)
Effects of
hypoxia
(Table
I)(a) On baseline
variables. During hypoxia, 02
saturation fell from 99±0.4% to 83±1.4% (P < 0.05), with an increase in minuteventilation(Vs)
from 6.7±0.7to 11.8±1.0 liters/min
(P<0.05) (TableIII), and an increase in SNA from255±92to
354±107 U/min (P<0.05).MBPand centralvenous pressure
(CVP)did notchange.
(b)
Duringphenylephrine. During
PEalone,
MBP in-creasedby - 10 mmHg (P<0.05)
and heartrateslowedby
- 11 beats/min (P< 0.05). CVPincreased
from 0.7±0.5 toTable L ComparisonofEffectsofHypoxia Alone andduring Phenylephrine Infusion
Hypoxia
Baseline Hypoxia Phenylephrine +phenylephrine
02Sat(%) 99±0.4 83±1.4* 99±0.5
84±1.8*4
PCO2
(mmHg)
41±1.3 40±1.3 40±1.8 41±1.4MBP(mmHg) 80.0±3.6 80.3±3.9
89.7±2.3*0
93.0±3.5*1
HR(beats/min) 65.8±2.4 83.2±4.4*54.5±3.1*1
65.7±4.3#
CVP(mmHg) 0.7±0.5 0.3±1.02.7±1.0*1
3.3±0.9*0VE
(liters/min) 6.7±0.7 11.8±1.0*7.i±0.81
10.8±0.8**
SNA(U/min) 255±92 354±107* 87±45§ 50±23*§n=6.*P<0.05 comparedtobaseline;tP<0.05comparedto PE
alone;§P<0.05 comparedtohypoxiaalone.
Conltro
SNA
RESP
PE
SPA
Hypoxia
PE .
PE+Hypoxba
Figure
1.Recordings
ofsympathetic
nerveac-tivity (SNA)
andrespi-ratory
tracings
(RESP)
inasingle
subject,
atbaseline
(control;
topleft), during hypoxia
(top
right), during
PEinfusion
(bottom left),
and
during
the combi-nation ofhypoxia
and PEinfusion. Expirationisindicated byupward movement of there-spiratorytraceand inspiration by downward movement. Note that
hypoxiaalone increasedSNA,whereas PE suppressed SNA. Most
importantly, hypoxia duringPEresulted in aslight further suppres-sion of SNA.
2.7±1
mmHg (P
<0.05).
VE
did notchange,
but SNA fellstrikingly
from327±132to87±45U/min (P
<0.05).
With
hypoxia
during PE, MBPwas93±3.5 mmHg (- 13mmHg
greater thanduring hypoxia alone) (P<0.05).How-ever, 02 saturation
(84±1.8%)
andVE (10.8±0.8
liters/min)
weresimilartovalues during hypoxiaalone(Table III).With
addition of
hypoxia during PE,
SNA failed to increase and indeed tended todecreaseeven further than levels recordedduring
PEalone(87±45
to50±23U/min) (Figs.
1 and2).
(II)
Effects ofhypercapnia (Table
II)
(a)
On baseline variables.During
hypercapnia, end tidalCO2
increasedfrom40±2.7 to53±1.5 mmHg (P<0.05), withan
increasein
VE
from 6.7±0.6to19.2±2.4 liters/min (P<0.05)
(Table III) andan increase inSNA from 116±39 to234±72
U/min
(P<0.05). MBPincreasedfrom76.5±3.1to82.3±3.1 mmHg(P
<0.05) and CVP increased from 0.8±0.6to1.8±0.4 mmHg (P<0.05).
(b)
During phenylephrine. During
PE alone, MBPin-creased to 84.7±2.3 mmHg
(P
<0.05), heart rateslowedto55.0±5.1 beats/min (P<0.05), and CVPincreasedto3.2±0.6
Minute
Figure
2.Group
dataMSNA ventilation
(units/mitt) (Imin) for sixsubjects showing
2.0 . theeffects ofhypoxia
35
m
105(H),
phenylephrinealone (PE), andhypoxia
300- .9.0- duringPE(PE+H)on
sympathetic
nerveac-250- T tivity (SNA; left) and
200- 6.0- minuteventilation
(right), as compared to
50- C,4.5_ measurements recorded
..
t~h-
NS,1.
3.0_
-..
,.
.
'Note
in thecontrol (C)state. thathypoxia
in-creased SNA andventi-MOP
~
~ ~ ~~~~ ~
lation. PEmarkedlysuppressed SNA.
Hyp-C H PEPE. C H PEPE4H *
MBP 8t 8290 93
oxia
duringPE resulted(mmo~g)
in
noincrease
(andin-deedatendencytoa
decrease) in SNA. Baroreflexstimulationby PE,however,did not significantly reduce the ventilatory response to hypoxia. Shownatthe bottom of the left panelarevalues for MBPduringeach of the inter-ventions. (*P < 0.05).
Table II. Comparison ofEffects ofHypercapnia Alone
and during Phenylephrine Infusion
Hypercapnia Baseline Hypercapnia Phenylephrine +phenylephrine
02 Sat (%) 99±0.4 100±0.0 99±0.4 100±0.0
PCO2(mmHg) 40±2.7 53+1.5* 41±1.4 55±0.5*t MBP(MmHg) 76.5±3.1 82.3±3.1* 84.7±2.3* 93.7±1.7*tf
HR
('beats/min)
67.2±5.7 71.2±6.5 55.0±5.1* 61.3±4.7§CVP(mmHg) 0.8±0.4 1.8±0.4* 3.2±0.6* 5.2+0.7*$§
VE
(fliters/min)
6.7±0.6 19.2±2.4* 5.7±0.620.2±1.8**
SNA(U/min) 116±39 234±72* 32±25* 61±24**1
n=6.*P<0.05 comparedtobaseline; tP <0.05 comparedtoPE
alone;IP <0.05 comparedtohypercapniaalone.
mmHg (P <0.05). VE didnotchange. SNA fellto 32±25
U/
min (P <0.05).
With hypercapnia during PE, MBP rose to 93.7±1.7
mmHg (- 11 mmHg greater thanduring hypercapnia alone) and CVP increased furtherto5.2±0.7 mmHg(P<0.05).
De-spite the increasein MBPandCVPwith the addition of
hyper-capnia,
SNA almost doubled(from 32±25to61±24 U/min;P<0.05).
YE
(20.2±1.8 liters/min) and end tidal CO2 (55±0.5 mmHg)were similartolevels recorded during hypercapnia alone(Table III; Figs. 3 and 4).(III)
Effects
ofthe cold pressor test
(a)
Onbaseline variables. CPT increased
MBP(from 77±1.9
to90.5±5.9;P<0.05) and SNA (from 162±40to514±182;P
<0.05).CVP and
VE
didnotchangesignificantly.(b)
Duringphenylephrine.
CPTduring PE resulted in afur-therincrease in MBPfrom 91±3.2 (PE alone) to 107±6.4 mmHg (P < 0.05). CVP was 5.2±0.5 during CPT alone,
5.7±0.5 duringPE alone, and 5.7±0.8 withCPTduringPE.
Despite the increase in MBP with CPTduring PE, SNA in-creasedfrom5.5±1.9 U/min during PE alone to 285±128
U/
min
during
CPTand PE(Fig.5).Discussion
Themajornewfinding in this studywasinhibition of the
sym-patheticnerveresponsetohypoxia (peripheral chemoreceptor stimulation) by baroreceptor activationinhumans.
Astrength ofthis studywasthe directmeasurementof
sym-patheticnerveactivity using microneurography. This enabled ananalysis of these reflex interactions by providingameasure
of the efferent sympathetic neural response to simultaneous activation of both baroreceptor and chemoreceptor afferents thatisnotinfluenced by direct effects of hypoxia, hypercapnia, andphenylephrine.
Alimitation of the studywasthe fact that theuse
ofphenyl-ephrinetoactivatebaroreceptors raises centralvenouspressure
aswellassystemic arterialpressure.Hence it isnotpossibleto
distinguish whether the interactions evidentaredueto activa-tion of arterial baroreceptorsorofcardiopulmonaryreceptors orboth. In addition, wehavenotinthisstudy examined the effectsofbaroreflex deactivation onthe chemoreceptor re-sponses.
A possible criticism is that the use of phenylephrine (an
alpha agonist and thereforea vasoconstrictor)toactivate the baroreflexmaybeassociated with direct effects of phenyleph-rine (independent of the effects of the increased arterial
pres-sure)onthe chemoreceptors. If thiswereso,and
vasoconstric-tionoccurred in the chemoreceptors,wewouldexpectan
aug-mentation rather thananinhibition oftheresponsetohypoxia, since vasoconstriction would increase the hypoxic stimulus. Furthermore, intravenous infusions of norepinephrine
in-crease,ratherthandecrease the respiratoryresponsetohypoxia inman(13). Inanyevent,anyeffects ofphenylephrineonthe baroreflex itself is unlikely to have influenced our findings,
sinceanysuch effect would bepresentduring both the hypoxic andhypercapnicstresses. Withregardtopossible effects of
phenylephrineonthebaroreflexes, the doses ofphenylephrine
used in thisstudy donotsensitize the arterial baroreceptorsto
graded levels of neckpressure(14).
We have confirmed earlier human studiesdemonstrating
sympathetic neural activation by both hypoxia and
hypercap-TableIII.MinutebyMinuteChangesin02 Saturation, EndTidal C02, and VentilationduringHypoxiaandHypercapnia
with and withoutPhenylephrine
Baseline Minute 1 Minute 2 Minute 3 Minute 4 Minute 5
Hypoxia(n=6)
02
Sat(%) 99±0.489±1.9**
85±1.0** 83±1.3* 80±2.1* 78±2.4*VE
(liters/min)
6.7±0.79.8±1.0*
11.4±1.0*t 12.5±1.4* 13.3±1.1* 12.8±1.2*Hypoxia+PE(n=6)
02Sat(%) 99±0.5 92±1.5*t 84±1.4** 82±2.5* 79±1.5* 77±2.5*
VE
(liters/min)
7.1±0.99.1±1.0*4
10.6±1.1I 11.7±0.7* 11.8±0.6* 11.6±0.7*Hypercapnia (n=5)
PCO2 (mmHg) 42±0.8 53±1.0** 54±1.0* 55±1.1* 56±0.7* 56±0.7*
VE
(liters/min)
6.3±0.611.5±1.3*4
17.8±2.6*t 19.0±2.2* 24.3±3.3* 26.1±3.4*Hypercapnia + PE (n=5)
PCO2
(mmHg) 42±0.853±1.0**
54±1.0* 55±0.6* 56±0.5* 56±0.4VE
(liters/min)
6.7±0.712.0±1.1*$
19.0±1.8**
23.0±2.2* 25.4±2.6* 26.7±2.6**P <0.05 compared to
baseline;t
P <0.05 compared to the previous minute.02
Sat, oxygen saturation. Note: The02
saturation and venti-latory responses over timeforhypoxia alone and hypoxia and phenylephrine were similar, as were thepCO2andventilatory responses over time forhypercapniaaloneandhypercapniaandphenylephrine.Figure 3. Recordingsof sympathetic nerve
ac-tivity (SNA)and
respi-ratorytracings(RESP) inasingle subject, at
baseline (control;top
left), hypercapnia (top right),during PE infu-sion(bottom left), and during hypercapnia im-posed during PE infu-sion. Note that hyper-capnia alone increased SNA, andPEsuppressed SNA. However, de-spitethe suppression by PE, superimposed hypercapnia (unlike hypoxia) still elicitedasubstantialSNAresponse.
nia.More importantly, in this studywehave shown in humans
thatbaroreceptoractivation inhibits the sympatheticresponses tohypoxia. Thisbaroreceptor-chemoreceptorinteractionwas
previously described in animals (5, 6, 15, 16). In humans, this interaction appearstobespecific for hypoxia, which activates primarily peripheralchemoreceptors.Incontrast,during baro-reflex activation, sympatho-excitation still occursduring
hy-percapnia,which stimulates primarily centralchemoreceptors.
Sympatho-excitation is also present in response toa potent
nonspecificstimulus suchasthe coldpressortest.This specific-ity ofthe interaction between the baroreceptors and the periph-eral(butnotcentral)chemoreceptorsis remarkably similarto aninteraction thatwereported earlier where ventilation (and
thereby activation of thoracic afferents) inhibited the
sympa-theticresponsetohypoxia farmoreprofoundly than it
inhib-ited the sympathetic response to hypercapnia (4). These
se-lective interactions may be explained by neurophysiological studies demonstrating that carotid baroreceptor and
chemore-ceptorneurons aredistributedincloseproximityinthesolitary and paramedian reticular nucleiinthe medulla, such that
in-terneuronal connections mightfacilitate interactions between
these reflexes (17).
Minute Figure4. Group data
MSNA Ventilation
(unitsilmin) (1/min) for six subjects showing
theeffects of hypercap-nia(C02),PEalone
255 20- X (PE),andhypercapnia
.
duringPE(PE+C02), . showing sympatheticnerveactivity (MSNA; left) and minute
ventila-tion(right),as
com-paredtothe
measure-mentrecorded in the
CO CCOOE control(C)state.
Hy-MP 7782 85 94 percapnia increased
(mmHg)
both SNA and
ventila-tion. Despitethemarkedsuppressionof SNAby PE,hypercapnia duringPEstillelicitedanincrease inSNA,unlike thecomplete
sup-pressionseenduring hypoxia (Fig. 2).Baroreflex activationbyPEdid notinfluence theventilatoryresponsetohypercapnia.Values for
MBPobtainedduringthe various interventionsareshown below the
figureontheleft.
Contro
SNA
RESP
PE
sd _
REW
WIr Figure
5.
Recordingsof sympatheticnerve ac-tivity (SNA) andrespi-ratory
tracings (RESP)
inasinglesubject,atrow baseline(control; top
PE Orr left),duringthe cold ~~A~~lA pressor test(CPT;top
~ right), duringaPE infu-sion
(bottom
left),
andduringtheCPT
im-posed duringthe PE in-fusion. Baroreflex acti-vationby PE didnotabolish the SNAresponsetoCPT (compare the
responsetohypoxia in Fig. 1).
Anunexpectedfindinginthis studywasthatSNAtendedto
decrease(not increase)whenhypoxiawasimposed
during
baro-receptoractivation withphenylephrine. Activation ofthebaro-reflexmayexplain the failure of SNAtorisewhenperipheral
chemoreceptorsarestimulated by hypoxia, but whywould
SNA tendto decrease? There aretwo possibleexplanations.
First, when hypoxiawasimposed during PE, therewas aslight
increase in bloodpressurewhich would produce further
barore-flex inhibition of SNA. Second, when hypoxiawas imposed
during PE, therewas an increase in ventilation which could
inhibit SNA by activating thoracic stretchreceptors.
We didnotsee aninhibitory influence ofbaroreceptor
acti-vationonthe ventilatoryresponsetohypoxia,ashas been
re-ported in animals (5). Thismaybeexplained by the fact that the magnitude of thepressurechange in animal studies (> 100
mmHg) far exceeded thepressureincrease in this study (- 10
mmHg). The significance of this absence ofany ventilatory
inhibition despite sympathetic inhibition is that thebaroreflex
chemoreflex interaction may more profoundly influence the sympathetic limb of the chemoreflexascomparedtothe venti-latory limb.
The results of this study shed lightonourearlierreportof sympathetic hyperresponsivenesstohypoxia in borderline hy-pertensives (18). We speculate that the barorefleximpairment
known tooccur in hypertension, may result ina loss of the
inhibitory tonicor restraining influence of baroreceptorson
theexcitatoryeffect ofchemoreceptors during hypoxia.
In conclusion, these data demonstrateaspecific interaction
between baroreceptors and peripheral chemoreceptors in
regu-lation of sympatheticnerveactivity in normal humans. Activa-tionofbaroreceptorsby increases in arterialpressurewith
phen-ylephrinemarkedlyinhibit thesympatho-excitatory response
tostimulation of peripheralchemoreceptorswith hypoxia. Thisinhibitory influence of baroreceptor activation wasnot
observed during stimulation of central chemoreceptors with
hypercapnia.
Acknowledgments
The authors wishtothankMary Clary for'experttechnical assistance andNancy Stampfortypingthemanuscript.
The workwascarriedoutwithsupportof grantsHL-24962 and
HL-14388 from the NationalHeart,Lung,and BloodInstitute ofthe National Institutes of Health.
1956 V. KSomers,A. L.Mark,and F. M. Abboud ConW
SNA
RESP *~<P
PE
IHypwcapnla
.. Hy.pecp PE+Hypepnis
SNA
References
1.Calvelo,M.G.,F. M.Abboud, D.R.Ballard, andW.Abdel-Sayed. 1970. Reflex vascularresponsestostimulation ofchemoreceptorswith nicotineand
cyanide: activation of adrenergic constrictioninmuscleandnoncholinergic dila-tationindog'spaw.Circ. Res.27:259-276.
2. Walker,B. R.,and B. L. Brizzee. 1990. Cardiovascularresponsestohypoxia
andhypercapnia in barodenervatedrats.J.Appl.Physiol. 68:678-686. 3. Somers,V.K.,A.L.Mark, D. C. Zavala, andF. M.Abboud.1989.
Influ-enceofventilation and hypocapniaonsympatheticnerve responsestohypoxia in normal humans. J. Appl. Physiol. 67:2095-2100.
4.Somers,V.K.,A. L.Mark,D.C.Zavala, andF. M.Abboud. 1989. Con-trasting effects of hypoxiaandhypercapniaonventilation and sympathetic activ-ity in humans.J.Appl.Physiol. 67:2101-2106.
5.Heistad,D.D.,F. M.Abboud,A.L.Mark, andP.G. Schmid. 1975. Effect of baroreceptoractivityonventilatoryresponsetochemoreceptorstimulation. J.
Appl.Physiol. 39:411-416.
6. Mancia, G.1975.Influence ofcarotidbaroreceptorsonvascularresponses
tocarotidchemoreceptor stimulationinthedog. Circ. Res. 36:270-276.
7. Wade, J.G., C. P.Larson, Jr., R. F.Hickey,W. KEhrenfeld,and J. W.
Severinghaus. 1970. Effect of carotidendarterectomyoncarotidchemoreceptor andbaroreceptorfunction inman.N.Engl.J. Med.282:823-829.
8.Lugliani, R.,B. J.Whipp,C.Seard,and K. Wasserman. 1971. Effect of
bilateralcarotid-bodyresectiononventilatorycontrolat restandduringexercise
inman.N.Engl.J.Med., 285:1105-1111.
9.Komer,P.I. 1979.HandbookofPhysiology.TheCardiovascular System.
The Heart.Sect.2, Vol.I,Chap. 20. American Physiological Society, Bethesda, MD.691-739.
10. Gelfand, R., and C. J. Lambertsen. 1973. Dynamic respiratory response to abruptchangeofinspired CO2 at normal andhigh P02.J.Appl.Physiol. 35:903-913.
11. Vallbo, A. B., K.-E. Hagbarth, H. E.Torebjork,and B. G.Wallin.1979. Somatosensory,proprioceptive, andsympatheticactivity in humanperipheral
nerves.Physiol. Rev.59:919-957.
12. Mark, A. L., R.G. Victor, C. Nerhed, and B. G. Wallin. 1985.
Microneu-rographic studiesof the mechanisms ofsympathetic nerveresponses to static
exercisein humans.Circ. Res. 57:461-469.
13.Cunningham, D. J. C., E. N. Hey, J. M. Patrick, and B. B. Lloyd. 1963. Theeffectof noradrenaline infusion on the relation between pulmonary ventila-tion and the alveolarP02andPCO2sinman.Ann.NYAcad.Sci. 109:756-770. 14.Ferguson, D. W., F. M. Abboud, andA. L.Mark.1985.Relative
contribu-tionof aorticandcarotidbaroreflexestoheartratecontrol inmanduring steady
state anddynamic increases in arterial pressure. J. Clin.Invest.76:2265-2274. 15.Heistad, D. D., F. M. Abboud, A. L. Mark, and P. G. Schmid. 1974. Interaction of baroreceptor and chemoreceptorreflexes.Modulation of the che-moreceptorreflex by changes in baroreceptor activity. J.Clin.Invest. 53:1226-1236.
16.Mancia, G., J.T.Shepherd, and D. E. Donald. 1976. Interplay among carotidsinus,cardiopulmonary,andcarotidbodyreflexesindogs.Am.J.Physiol.
230: 19-24.
17.Miura, M., andD.J.Reis. 1972. The roleofthesolitaryandparamedian
reticular nuclei in mediating cardiovascularreflexresponsesfromcarotid baro-and chemoreceptors.J. Physiol. (Lond.).223:525-548.
18. Somers, V. K., A. L. Mark, and F. M. Abboud. 1988. Potentiationof sympatheticnerveresponsestohypoxia in borderlinehypertensive subjects. Hy-pertension(Dallas). 11:608-612.